Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Brief Summary: This is a study to determine if early, long-term low dose sirolimus is effective for preventing progression to more advanced stages.